Energy blogs

  • Gosreports
    30 Jun 2015 - 20:07 by Gosreports

    2015 Global The Energy Efficient IT Equipment Industry Report is a professional and in-depth research report on the world’s major regional market conditions of the The Energy Efficient IT Equipment industry, focusing on the main regions (North America, Europe and Asia) and the main countries (United States, Germany, Japan and China).

    The report firstly introduced the The Energy Efficient IT Equipment basics: definitions, classifications, applications and industry chain overview; industry policies and plans; product specifications; manufacturing processes; cost structures and so on. Then it analyzed the world’s main region market conditions, including the product price, profit, capacity, production, capacity utilization, supply, demand and industry growth rate etc. In the end, the report introduced new project SWOT analysis, investment feasibility analysis, and investment return analysis.

    The report includes six parts, dealing with: 1.) basic information; 2.) the Asia The Energy Efficient IT Equipment industry; 3.) the North American The Energy Efficient IT Equipment industry; 4.) the European The Energy Efficient IT Equipment industry; 5.) market entry and investment feasibility; and 6.) the report conclusion.

    More information: http://www.gosreports.com/global-the-energy-efficient-it-equipment-industry-2015-market-research-report/

    Joanna | Executive - International Business and partner Relations
    Gos International Inc.
    Gos International Inc. is one of the leading distributors of market research reports in the world today.
  • Marketresearchri
    30 Jun 2015 - 06:11 by Marketresearchri

    BioInvent International AB - Product Pipeline Review - 2014

    Summary

    Global Markets Direct's, 'BioInvent International AB - Product Pipeline Review - 2014', provides an overview of the BioInvent International AB's pharmaceutical research and development focus.

    This report provides comprehensive information on the current therapeutic developmental pipeline of BioInvent International AB's, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects.

    Browse Full Report With TOC @ http://www.radiantinsights.com/research/bioinvent-international-ab-product-pipeline-review-2014

    Global Markets Direct's report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct's proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct's team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis.

    The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.

    Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

    Scope

    - The report provides brief overview of BioInvent International AB including business description, key information and facts, and its locations and subsidiaries

    - The report reviews current pipeline of BioInvent International AB's human therapeutic division and enlists all their major and minor projects

    - The report features product description and descriptive mechanism of action for key pipeline products along with the product's developmental history and major milestones

    Reasons to buy

    - Evaluate BioInvent International AB's strategic position with total access to detailed information on its product pipeline

    - Assess the growth potential of BioInvent International AB in its therapy areas of focus

    - Identify new drug targets and therapeutic classes in the BioInvent International AB's R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas

    About Radiant Insights

    Radiant Insights is a platform for companies looking to meet their market research and business intelligence requirements. We assist and facilitate organizations and individuals procure market research reports, helping them in the decision making process. We have a comprehensive collection of reports, covering over 40 key industries and a host of micro markets. In addition to over extensive database of reports, our experienced research coordinators also offer a host of ancillary services such as, research partnerships/ tie-ups and customized research solutions.

    For more information visit, Radiant Insights

    Contact Details:

    Michelle Thoras

    Corporate Sales Specialist, USA

    Radiant Insights, Inc

    Phone: 1-415-349-0054

    Toll Free: 1-888-202-9519

     

  • Marketresearchri
    30 Jun 2015 - 06:09 by Marketresearchri

    BioDelivery Sciences International, Inc. - Product Pipeline Review - 2014

    Summary

    Global Markets Direct's, 'BioDelivery Sciences International, Inc. - Product Pipeline Review - 2014', provides an overview of the BioDelivery Sciences International, Inc.'s pharmaceutical research and development focus.

    This report provides comprehensive information on the current therapeutic developmental pipeline of BioDelivery Sciences International, Inc.'s, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects.

    View summary of this report @ http://www.radiantinsights.com/research/biodelivery-sciences-international-inc-product-pipeline-review-2014

    Global Markets Direct's report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct's proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct's team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis.

    The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.

    Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

    Scope

    - The report provides brief overview of BioDelivery Sciences International, Inc. including business description, key information and facts, and its locations and subsidiaries

    - The report reviews current pipeline of BioDelivery Sciences International, Inc.'s human therapeutic division and enlists all their major and minor projects

    - The report features product description and descriptive mechanism of action for key pipeline products along with the product's developmental history and major milestones

    Reasons to buy

    - Evaluate BioDelivery Sciences International, Inc.'s strategic position with total access to detailed information on its product pipeline

    - Assess the growth potential of BioDelivery Sciences International, Inc. in its therapy areas of focus

    - Identify new drug targets and therapeutic classes in the BioDelivery Sciences International, Inc.'s R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas

    About Radiant Insights

    Radiant Insights is a platform for companies looking to meet their market research and business intelligence requirements. We assist and facilitate organizations and individuals procure market research reports, helping them in the decision making process. We have a comprehensive collection of reports, covering over 40 key industries and a host of micro markets. In addition to over extensive database of reports, our experienced research coordinators also offer a host of ancillary services such as, research partnerships/ tie-ups and customized research solutions.

    For more information visit, Radiant Insights

    Contact Details:

    Michelle Thoras

    Corporate Sales Specialist, USA

    Radiant Insights, Inc

    Phone: 1-415-349-0054

    Toll Free: 1-888-202-9519

     

  • Marketresearchri
    30 Jun 2015 - 06:09 by Marketresearchri

    BioDelivery Sciences International, Inc. - Product Pipeline Review - 2014

    Summary

    Global Markets Direct's, 'BioDelivery Sciences International, Inc. - Product Pipeline Review - 2014', provides an overview of the BioDelivery Sciences International, Inc.'s pharmaceutical research and development focus.

    This report provides comprehensive information on the current therapeutic developmental pipeline of BioDelivery Sciences International, Inc.'s, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects.

    View summary of this report @ http://www.radiantinsights.com/research/biodelivery-sciences-international-inc-product-pipeline-review-2014

    Global Markets Direct's report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct's proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct's team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis.

    The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.

    Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

    Scope

    - The report provides brief overview of BioDelivery Sciences International, Inc. including business description, key information and facts, and its locations and subsidiaries

    - The report reviews current pipeline of BioDelivery Sciences International, Inc.'s human therapeutic division and enlists all their major and minor projects

    - The report features product description and descriptive mechanism of action for key pipeline products along with the product's developmental history and major milestones

    Reasons to buy

    - Evaluate BioDelivery Sciences International, Inc.'s strategic position with total access to detailed information on its product pipeline

    - Assess the growth potential of BioDelivery Sciences International, Inc. in its therapy areas of focus

    - Identify new drug targets and therapeutic classes in the BioDelivery Sciences International, Inc.'s R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas

    About Radiant Insights

    Radiant Insights is a platform for companies looking to meet their market research and business intelligence requirements. We assist and facilitate organizations and individuals procure market research reports, helping them in the decision making process. We have a comprehensive collection of reports, covering over 40 key industries and a host of micro markets. In addition to over extensive database of reports, our experienced research coordinators also offer a host of ancillary services such as, research partnerships/ tie-ups and customized research solutions.

    For more information visit, Radiant Insights

    Contact Details:

    Michelle Thoras

    Corporate Sales Specialist, USA

    Radiant Insights, Inc

    Phone: 1-415-349-0054

    Toll Free: 1-888-202-9519

     

  • Wayne31jan
    30 Jun 2015 - 06:01 by Wayne31jan

    The global installed capacity in the offshore wind energy market stood at 7,045.4 MW in 2013 and is expected to reach 52,120.9 MW by 2022 at a CAGR of 25.0% from 2014 to 2022. Annual installations stood at 1,629.4 MW in 2013 and are expected to reach 7,228 MW by 2022, at a CAGR of 19.6% from 2014 to 2022. In the 2013 to 2022 period, total capacity additions of 46,704.9 MW are expected. In terms of investment, USD 7,875.5 million of new investments were required for capacity additions in 2013. This number is expected to increase to USD 27,387.5 million in 2022, at a CAGR of 16.4% from 2014 to 2022. Total investments in the 2013−2022 period for capacity additions are expected to reach USD 194,708.9 million.

     

    Browse Offshore Wind Energy Market Report with Full TOC at http://www.transparencymarketresearch.com/offshore-wind-energy-market.html

     

    Europe currently is the only region which has invested significantly in developing its offshore wind energy sector. Europe is followed by Asia Pacific, wherein China is the only country that has separate targets for offshore wind energy installations. North America and Rest of the World (RoW) are yet to construct and commission utility-scale offshore wind energy projects. Development of the offshore wind energy sector in the U.S. has not yet taken off, despite numerous projects being at various stages of the planning phase. Technology for drawing grid connections from offshore wind farms is currently present in the U.S. However, absence of regional transmission operators (RTOs), especially in the south-east region of the country, makes it extremely difficult for offshore wind farms to justify their costs as compared to benefits. Similarly, restricted funding channels and negative public sentiment surrounding the technology has also taken a toll on the offshore wind energy sector in the U.S. The Cape Wind Project is among the offshore wind energy projects that have been involved in controversies. The Cape Wind Project, which if commissioned, would have connected 468 MW of offshore wind energy capacity to the grid. Although not yet shelved, the project’s future is uncertain, post the cancellation of power purchase contracts by two utilities. Similarly, in Canada, Ontario has put a moratorium on offshore wind development activities. Amidst the low electricity prices prevalent in Canada, it is extremely difficult to support the development of the offshore wind sector by weighing costs against benefits.

     

    However, in Europe, the investment climate is positive and is expected to remain so throughout the forecast period. Europe witnessed nearly 1,567 MW of new capacity additions in the offshore wind sector in 2013, which was 34% higher than the previous year. The U.K. currently is the largest market for offshore wind energy in Europe. With the implementation of the new Energy Act in the country in December 2013 along with the implementation of the Electricity Market Reform Package, significant capacity additions can be expected in the future. Involvement of market players such as Siemens who have made investments, in collaboration with Associated British Ports, for the construction of wind turbine manufacturing facilities would go a long way in resolving supply chain bottlenecks as well as create employment (~1,000 jobs) for locals. Despite numerous advantages, the offshore wind energy sector in the U.K. suffers from a funding gap with a distinct mismatch between capacity additions planned and subsidies available under the CfD scheme. With projects of 5 GW of capacity expected to enter the planning phase in 2015, resolution of the funding gap issue remains to be seen. Germany’s prospects for offshore wind are even brighter with 9 GW of new capacity in the pipeline. Currently, Germany has a share of almost 30% amongst all consented European offshore wind farms, which are scheduled to go online within the forecast horizon. Stronger port infrastructure and an inherent locational advantage render offshore wind energy companies operating in the country well positioned to cater to the growing demand from both Germany as well as other European countries.

     

    Request for sample Free report http://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=5018

     

    Interactions with grid operators, however, vary significantly in different European countries. New amendments to the German Renewable Energy Act dictate that transmission systems operators (TSOs) pay compensation packages to offshore wind farm developers if they fail to draw grid connections on time. On the contrary, the regulatory framework in Denmark dictates that project developers pay the costs for drawing connections from the wind farm to the national grid. The manner in which the regulatory framework in various countries shape the interactions between TSOs and offshore wind developers would determine investor confidence and investments in the sector. The Netherlands, with its aggressive capacity addition targets, has brought in several reforms directed towards the offshore wind energy sector. Apart from an annual tendering of 700 MW, the government has also pre-designated offshore wind farm development zones and has plans to have TSOs construct five standardized grid connection platforms, exclusively for the ease of project developers.

     

    The offshore wind energy sector in Asia Pacific is expected to be mostly driven by China and partly by Japan. With recent revisions in its offshore wind energy target, China is set to add 10 GW of generating capacity by 2020. With only 39 MW of new capacity additions in 2013, the offshore wind energy sector in China has recently been the subject of much controversy and skepticism. Irrespective of the criticism, China has treaded carefully when it comes to the offshore wind energy sector primarily owing to the higher costs and operating risks involved. With 10 GW of capacity additions targeted within 2020, nearly 1 GW of capacity additions are required annually in China post 2015. Justifying and achieving such an aggressive capacity addition target would stretch the country’s offshore wind supply chain to its limits. Japan is also investing in offshore wind energy post the Fukushima disaster, as a replacement to nuclear energy. However, conflicts with the fishing industry, significantly higher water depths, and hostile operating conditions have emerged as major hurdles. In the future, both fixed base as well as floating foundations are anticipated to play an instrumental role in the wind energy sector in Japan. As for the Rest of the World region, capacity additions are not expected to be realized, barring certain pilot and demonstration projects, especially those in the offshore areas of Brazil.

     

    Browse press Release Of Offshore Wind Energy Market http://www.transparencymarketresearch.com/pressrelease/offshore-wind-energy-market.htm

     

    Offshore Wind Energy Market: Regional Analysis

     

    North America

     

    • U.S.

    • Rest of North America

       

    Europe

    • U.K

    • Germany

    • Denmark

    • Belgium

    • Sweden

    • Netherlands

    • Rest of Europe

     

    Asia Pacific

    • China

    • Japan

    • Rest of Asia Pacific

       

    Rest of the World

     

    About Us

     

    Transparency Market Research (TMR) is a global market intelligence company providing business information reports and services. The company’s exclusive blend of quantitative forecasting and trend analysis provides forward-looking insight for thousands of decision makers. TMR’s experienced team of analysts, researchers, and consultants use proprietary data sources and various tools and techniques to gather and analyze information.

     

    TMR’s data repository is continuously updated and revised by a team of research experts so that it always reflects the latest trends and information. With extensive research and analysis capabilities, Transparency Market Research employs rigorous primary and secondary research techniques to develop distinctive data sets and research material for business reports.

     

    Contact

    Mr. Nachiket

    90 State Street, Suite 700

    Albany, NY 12207

    Tel: +1-518-618-1030

    USA - Canada Toll Free: 866-552-3453

    Email: sales@transparencymarketresearch.com

    Website: http://www.transparencymarketresearch.com

    Visit : http://researcherville.blogspot.in/

     

Syndicate content